Skip to main content
. 2019 Apr 3;17(6):5193–5200. doi: 10.3892/ol.2019.10207

Figure 3.

Figure 3.

Differences in the expression of PD-L1 on mRNA level depending on the PD-L1 protein expression status of tumor cells in patients with non-small cell lung cancer. Higher relative expression of PD-L1 mRNA in the group with ≥50% (n=8) compared with the group with <50% (n=25) of tumor positive cells (TC, SP142). PD-L1, programmed death ligand 1; miR/miRNA, microRNA; TC, tumor cells.